Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Net Asset Quality Index
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a Net Asset Quality Index of 87.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs3.17 Billion minus total liabilities of Rs405.05 Million yields net assets of Rs2.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read JAGSNPHARM current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Jagsonpal Pharmaceuticals Limited Net Asset Quality Index Over Time (2006–2026)
This chart shows how Jagsonpal Pharmaceuticals Limited's Net Asset Quality Index has evolved across 21 annual periods from 2006 to 2026. As of March 2026, the index stands at 87.2%, representing net assets of Rs2.76 Billion against total assets of Rs3.17 Billion INR. For live market cap and overall valuation, see how much is Jagsonpal Pharmaceuticals Limited worth.
Annual Net Asset Quality Index for Jagsonpal Pharmaceuticals Limited (2006–2026)
The table below presents the year-by-year Net Asset Quality Index for Jagsonpal Pharmaceuticals Limited from 2006 to 2026, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is Jagsonpal Pharmaceuticals Limited's equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 87.2% | Rs2.76 Billion | Rs3.17 Billion | Rs405.05 Million | ▲ +1.0 pp |
| 2025 | 86.2% | Rs2.40 Billion | Rs2.78 Billion | Rs383.10 Million | ▼ -0.1 pp |
| 2024 | 86.3% | Rs1.87 Billion | Rs2.17 Billion | Rs296.76 Million | ▲ +4.8 pp |
| 2023 | 81.5% | Rs1.59 Billion | Rs1.95 Billion | Rs360.56 Million | ▲ +3.8 pp |
| 2022 | 77.7% | Rs1.31 Billion | Rs1.68 Billion | Rs375.99 Million | ▲ +3.4 pp |
| 2021 | 74.3% | Rs1.22 Billion | Rs1.64 Billion | Rs422.73 Million | ▼ -1.3 pp |
| 2020 | 75.6% | Rs1.11 Billion | Rs1.47 Billion | Rs359.21 Million | ▼ -1.4 pp |
| 2019 | 76.9% | Rs1.04 Billion | Rs1.36 Billion | Rs313.11 Million | ▲ +1.4 pp |
| 2018 | 75.5% | Rs980.47 Million | Rs1.30 Billion | Rs317.68 Million | ▼ -1.5 pp |
| 2017 | 77.1% | Rs1.10 Billion | Rs1.43 Billion | Rs326.97 Million | ▲ +15.3 pp |
| 2016 | 61.8% | Rs983.64 Million | Rs1.59 Billion | Rs609.17 Million | ▼ -0.1 pp |
| 2015 | 61.9% | Rs954.26 Million | Rs1.54 Billion | Rs587.94 Million | ▼ -1.2 pp |
| 2014 | 63.1% | Rs985.89 Million | Rs1.56 Billion | Rs576.68 Million | ▼ -1.2 pp |
| 2013 | 64.3% | Rs983.71 Million | Rs1.53 Billion | Rs546.30 Million | ▲ +1.2 pp |
| 2012 | 63.1% | Rs984.69 Million | Rs1.56 Billion | Rs576.30 Million | ▼ -4.9 pp |
| 2011 | 68.0% | Rs929.14 Million | Rs1.37 Billion | Rs438.04 Million | ▼ -3.1 pp |
| 2010 | 71.1% | Rs875.70 Million | Rs1.23 Billion | Rs356.69 Million | ▲ +5.8 pp |
| 2009 | 65.3% | Rs801.68 Million | Rs1.23 Billion | Rs426.09 Million | ▲ +7.7 pp |
| 2008 | 57.6% | Rs750.34 Million | Rs1.30 Billion | Rs552.21 Million | ▲ +8.4 pp |
| 2007 | 49.2% | Rs724.98 Million | Rs1.47 Billion | Rs749.83 Million | ▼ -0.5 pp |
| 2006 | 49.6% | Rs702.35 Million | Rs1.42 Billion | Rs713.18 Million | — |